Maternal and Umbilical sTNF-R1 in Preeclamptic Pregnancies with Intrauterine Normal and Growth Retarded Fetus

REFERENCES

• Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 2004; 164(3)1049–1061
   PubMed Web of Science ®Google Scholar
• Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, Huppertz B. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 2001; 81(8)1143–1152
   PubMedGoogle Scholar
• Yu XW, Yan CF, Jin H, Li X. Tumor necrosis factor 1 expression and early spontaneous abortion. Int J Gynecol Obstet 2005; 88: 44–48
   PubMed Web of Science ®Google Scholar
• Anim-Nyame N, Gamble J, Sooranna SR, Johnson MR, Steer PJ. Microvascular permeability is related to circulating levels of tumour necrosis factor-α in pre-eclampsia. Cardiovasc Res 2003; 58: 162–169
   PubMedGoogle Scholar
• Beckmann I, Efraim SB, Vervoort M, Visser W, Wallenburg HC. Tumor necrosis factor-alpha in whole blood cultures of preeclamptic patients and healthy pregnant and nonpregnant women. Hypertens Pregnancy 2004; 23(3)319–329
   PubMed Web of Science ®Google Scholar
• Holcberg G, Huleihel M, Sapir O, Katz M, Tsadkin M, Furman B, Mazor M, Myatt L. Increased production of tumor ecrosis factor-α (TNF-α) by IUGR human placentae. Eur J Obstet Gynecol Reprod Biol 2001; 94: 69–72
   PubMed Web of Science ®Google Scholar
• Scalera F. Intracellular glutathione and lipid peroxide availability and the secretion of vasoactive substances by human umbilical vein endothelial cells after incubation with TNF-alpha. Eur J Clin Invest 2003; 33(2)176–182
   PubMedGoogle Scholar
• Serin IS, Özçelik B, Basbuð M, Kýlýc H, Okur D, Erez R. Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2002; 100(2)143–145
   PubMed Web of Science ®Google Scholar
• Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC, King IB, Zebelman AM, Luthy DA. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampisa. Am J Epidemiol 1999; 149(4)323–329
   PubMed Web of Science ®Google Scholar
• Williams MA, Mahomed K, Farrand A, Woelk GB, Mudzamiri S, Madzime S, King IB, McDonald GB. Plasma tumor necrosis factor-α receptor p55(sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean women. J Reprod Immunol 1998; 40: 159–173
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Socol ML. Soluble tumor necrosis factor receptors and Interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996; 88: 420–427
   PubMed Web of Science ®Google Scholar
• Carr DB, McDonald GB, Brateng D, Desai M, Thach ChT, Easterling TR. The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia. Obstet Gynecol 2001; 98: 1109–1116
   PubMed Web of Science ®Google Scholar
• Crocker IP, Cooper S, Ong SC, Baker PN. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 2003; 162: 637–643
   PubMed Web of Science ®Google Scholar
• Knöfler M, Mösl B, Bauer S, Griesinger G, Husslein P. TNF-α/TNFRI in primary and immortalized first trimester cytotrophoblasts. Placenta 2000; 21: 525–535
   PubMed Web of Science ®Google Scholar
• Aderka D, Engelmann H, Wallach D. Soluble tumor necrosis factor receptors in health and disease. Tumor necrosis factor: Molecular and cellular biology and clinical relevance, W Fiers, WA Buurman. Karger, BaselGermany 1993; 191–198
   Google Scholar
• Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989; 264: 11974–11980
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Peyser MR, Lessing JB, Socol ML. Soluble tumor necrosis factor receptors in maternal plasma and second-trimester amniotic fluid. Am J Obstet Gynecol 1995; 173: 900–905
   PubMed Web of Science ®Google Scholar
• Nunez-Gonzalez JR, Sanabria-Vera CJ, Romero-Adrian T. Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and preeclamptic pregnant patients. Invest Clin 2001; 42(3)171–181
   PubMedGoogle Scholar
• Sanchez SE, Zhang C, Williams A, Ware-Jauregui S, Larrabure G, Bazul V, Farrand A. Tumor necrosis factor-α soluble receptor p55 (sTNFp55) and risk of preeclampsia in Peruvian women. J Reprod Immunol 2000; 47: 49–63
   PubMed Web of Science ®Google Scholar
• Carbo N, Lopez-Soriano FJ, Argiles JM. Tumor necrosis factor-alpha does not cross the rat placenta. Cancer Lett 1998; 128: 101–104
   PubMedGoogle Scholar